AAM
PFE icon

Azzad Asset Management’s Pfizer PFE Stock Holding History

Azzad Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,848
Closed -$218K – 312
2024
Q1 		$218K Sell
7,848
-45,562
-85% -$1.26M 0.03% 292
2023
Q4 		$1.54M Buy
53,410
+2,020
+4% +$61.1K 0.19% 185
2023
Q3 		$1.7M Buy
51,390
+1,798
+4% +$63.6K 0.24% 164
2023
Q2 		$1.82M Buy
49,592
+1,713
+4% +$66.7K 0.24% 155
2023
Q1 		$1.95M Buy
47,879
+1,706
+4% +$73.7K 0.28% 135
2022
Q4 		$2.37M Sell
46,173
-19,260
-29% -$923K 0.37% 98
2022
Q3 		$2.64M Buy
65,433
+1,218
+2% +$59.2K 0.27% 131
2022
Q2 		$2.98M Buy
64,215
+21,298
+50% +$1.09M 0.29% 120
2022
Q1 		$2.22M Buy
42,917
+8,161
+23% +$423K 0.32% 116
2021
Q4 		$2.05M Buy
34,756
+1,084
+3% +$53.7K 0.28% 143
2021
Q3 		$1.45M Buy
33,672
+1,336
+4% +$59.2K 0.21% 176
2021
Q2 		$1.27M Buy
32,336
+713
+2% +$27.7K 0.19% 197
2021
Q1 		$1.15M Buy
31,623
+9,675
+44% +$344K 0.19% 197
2020
Q4 		$808K Sell
21,948
-219
-1% -$8.03K 0.15% 212
2020
Q3 		$772K Buy
22,167
+1,266
+6% +$44.4K 0.16% 197
2020
Q2 		$648K Buy
+20,901
New +$710K 0.15% 209
2020
Q1 		– Sell
-22,106
Closed -$693K – 334
2019
Q4 		$693K Buy
22,106
+7
+0% +$249 0.08% 278
2019
Q3 		$689K Buy
+22,099
New +$804K 0.09% 273
2015
Q1 		– Sell
-20,757
Closed -$613K – 269
2014
Q4 		$613K Sell
20,757
-405
-2% -$11.6K 0.32% 127
2014
Q3 		$594K Buy
21,162
+7,181
+51% +$202K 0.34% 116
2014
Q2 		$394K Buy
13,981
+249
+2% +$7.1K 0.24% 175
2014
Q1 		$418K Buy
13,732
+722
+6% +$21.5K 0.28% 149
2013
Q4 		$378K Sell
13,010
-332
-2% -$9.66K 0.27% 156
2013
Q3 		$364K Hold
13,342
– – 0.3% 138
2013
Q2 		$364K Buy
+13,342
New +$369K 0.31% 137

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Azzad Asset Management's PFE Position: Q2 2024 in Review

Azzad Asset Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,848 shares — an estimated $218K sold.

Azzad Asset Management first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $2.98M in Q2 2022. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Azzad Asset Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Azzad Asset Management sold 7,848 Pfizer shares in Q2 2024, an estimated $218K.
  • Azzad Asset Management first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
  • Azzad Asset Management's Pfizer position peaked at $2.98M in Q2 2022.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Azzad Asset Management's 13F filing for Q2 2024, filed 30 Jul 2024.